Signal active
Bio
Corey Goodman is a renowned scientist, entrepreneur, educator, CEO, and corporate executive.
Goodman is Founding Partner of venBio, Adjunct Professor at the University of California, San Francisco, and Chair of the Board of Directors of Limerick BioPharma, Second Genome, Oligasis, and Ossianix, and member of the Board of NeuroTherapeutics Pharma. He is an elected member of the National Academy of Sciences, the American Academy of Arts and Sciences, and the American Philosophical Society.
Goodman was previously President of Pfizer's Biotherapeutics and Bioinnovation Center and a member of its Executive Leadership Team. He is a co-founder of Exelixis, Renovis, and Second Genome, and served as CEO of Renovis prior to its acquisition.
Goodman is also a member of the California Council on Science and Technology, the Pacific Institute, the Board of the McKnight Endowment Fund for Neuroscience, BayBio, Biotechnology Institute, Bay Area Science and Innovation Consortium, New York Stem Cell Foundation, QB3 (UCSF-UCB-UCSC) Industry Advisory Board, Stanford's BioX Biosciences Advisory Council, Spinal Muscular Atrophy Foundation, and is former Chair of the National Research Council's Board on Life Sciences.
During his academic career, Goodman spent over two decades as a professor of biology and neuroscience at Stanford and U.C. Berkeley, and earning numerous scientific awards such as the Alan T. Waterman Award from the National Science Board, the Gairdner International Award for Achievement in Medical Sciences, and the March-of-Dimes Prize in Developmental Biology.
Goodman received his B.S. from Stanford University, Ph.D. from U.C. Berkeley, and was a postdoctoral fellow at U.C. San Diego.
Location
San Francisco, California, United States, North America
Social
Primary Organization
2009
78
32
27
1-10
Financial Services, Venture Capital, Business Development, Life Science
Jobs history
8
Renovis
CEO
Invalid date - Current
venBio Partners
Managing Partner
Invalid date - Current
Axonis Therapeutics, Inc.
Executive Chairman and Founder
2020 - Current
Insamo
Board Member
2024 - Current
Axonis Therapeutics, Inc.
Executive Chairman
Invalid date - Current
FogPharma
Board Member
Invalid date - Current
Tallac Therapeutics
Co-Founder & Chairman
Invalid date - Current
Attralus
Board Member
Invalid date - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Corey Goodman is the Founding Partner at venBio Partners, based in United States, North America. With a background in Financial Services, Corey Goodman has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Investment portfolio
2
0
Personal investment
2
Annouced Date | Organization Name | Funding Round | Money Raised |
---|---|---|---|
Oct 01, 2019 | Queenly | Pre Seed Round - Queenly | 800.0K |
Aug 24, 2021 | MindRhythm | Seed Round - MindRhythm | 5.0M |
Partner investment
11
Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
---|---|---|---|---|
Jan 11, 2021 | FogPharma | Series C - FogPharma | venBio Partners | 107.0M |
Nov 21, 2022 | FogPharma | Series D - FogPharma | venBio Partners | 178.0M |
Feb 21, 2024 | Insamo | Seed Round - Insamo | venBio Partners | 12.0M |
Mar 01, 2024 | FogPharma | Series E - FogPharma | venBio Partners | 145.0M |
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.